Dr. Dean Winslow
Professor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine
Dean Winslow, MD is Professor of Medicine with appointments in the Divisions of Hospital Medicine and Infectious Diseases and is a Senior Fellow (courtesy) at CISAC/Freeman Spogli Institute. He has served on the Stanford faculty since 1998 and served from 2003-2008 as Co-Director of Stanford’s Infectious Diseases Fellowship Training Program. He was in private practice in Wilmington, Delaware where he started the state’s first multidisciplinary clinic for HIV patients in 1985. In 1988 he joined the DuPont Company where he worked both as a bench scientist on HIV drug resistance then later designed the clinical trials supporting FDA approval of efavirenz. In 1999 he became Vice President of Regulatory Affairs at Visible Genetics Inc. and led the FDA clearance of the TRUGENE HIV-1 drug resistance test. Dr. Winslow joined the staff at Santa Clara Valley Medical Center in 2003, where he served as Chief of the Division of AIDS Medicine and later as Chair of the Department of Medicine. In 2015 he was appointed Academic Physician-In-Chief at Stanford/ValleyCare and Vice Chair of the Department of Medicine. He was a Resident Fellow in Robinson House 2013-2017 and was visiting faculty at Oxford University in 2017. He was Lead Physician for the US Antarctic Program of the National Science Foundation 2019-2020 based at McMurdo Station, Antarctica. In 2021 he took leave from Stanford to lead the US COVID-19 Testing and Diagnostic Working Group.
Dr. Winslow received his medical education from Sidney Kimmel Medical College of Thomas Jefferson University, and is a distinguished graduate of the United States Air Force School of Aerospace Medicine and a graduate of the United States Air Force Air War College.